ASCP Members-Only (login required)

• Breakthroughs in US Manufacturing and Policy Due to Covid-19 Experience (June 26, 2020)
• Remdesivir and Emerging Treatments For COVID-19 (May 29, 2020)
• Phased Reentry: How Pharmacies and Pharmacists Respond to Entering Environments after Restrictions are Lifted (May 15, 2020)
• Vax Facts: Strategies Going Forward for Pneumococcal, Influenza and potential COVID Vaccines (May 8, 2020)
• How to Address Adjustment Disorders and Isolation in Our SNF AL and Community Patients (May 1, 2020)
• Rapid Guidance for COVID-19 (April 17, 2020)
• Field Guide for Consultant Pharmacists During the COVID-19 Crisis (April 10, 2020)
• Five-Star Antibiotic Stewardship Program (November 7, 2019)
• COVID-19 States Advancing the State of Pharmacy Practice (April 3, 2020)
• Drug Shortages The Crisis within the Crisis (March 27, 2020)
• Latest Guidance for Pharmacists from CMS and the National Task Force (March 23, 2020)
• Latest Guidance from the Front Lines (March 13, 2020)
• Implications for the Older Adult Population (March 6, 2020)

Free for Everyone

Covid-19 Response Update

Operation Warp Speed – Deploying a Vaccine in Senior Care
Reference: NASEM: Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine

Testing Out: COVID-19 Tests and Testing Procedures for Pharmacists (May 22, 2020)

Truths vs Myths in COVID-19 Is Hydroxychloroquine Working and are there Risks with Nebulizer Medications (April 24, 2020)

• NEW! eTrueNorth Bridge Access Program for uninsured and underinsured program details for LTC pharmacies
• Flowchart: Pharmacist Ordering of Paxlovid.
• FAQs on CMS Interim Final Rule
• Checklist for Preparation for Booster Immunization in PALTC
• PREP Act FAQs
• Pharmacist Quick Reference Guide (Member Login Required)
• Timeline of HHS Regulations and Legislative Activities Relating to the COVID-19 Pandemic and Pharmacy
• ASCP and National Pharmacy Association Response to EO #13924
• ASCP and Non-Pharmacy Letter to Congress
• ASCP COVID-19 (SARS-CoV-2) Medication Management FAQ
• Field Guide to Reduce Medication Burden during COVID-19
• Sample Pharmacy and Facility COVID-19 Policy & Procedures (member login required)
  
• US Deprescribing Network – Optimizing Medication Management during the COVID-19 Pandemic: Implementation Guide for the Post-Acute and Long-Term Care
• ASCP’s Remote MRR and Restocking CMS Guidance
• COVID-19 Discussion Board (member login required)
• On the Pharmacy Radar: COVID-19 and Older People
• COVID-19— Face Mask Effectiveness, Hand Sanitizer Shortages, and Rapid Medication Therapy Trials

• (FDA) EUA for COVID-19 pre-exposure prophylaxis - pemivibart
• (CDC) Provider Letter on Discontinuation of COVID-19 Vaccination Program
• (CMS) Expiring CMS Waivers for LTC
• (HHS) Evusheld, Molnupiravir and Paxlovid Therapeutic Locator
• (CDC) Preparedness Checklist for Nursing Homes and other Long-Term Care Settings
• (CDC) CDC's Strategies to Prevent the Spread of COVID-19 in Long-Term Care Facilities (LTCF)
• (CMS) CMS Suspension of Surveys
• (CMS) FAQ of Suspension of Survey Activity
• (CMS) Guidance for Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19) in nursing homes
• (DEA) DEA Publishes COVID-19 Information Addressing Handling of Controlled Substances
  
• (FDA) Compounding Guidelines for States in Addition to FDA Policy Allowing for Compounding of Drugs For COVID-19 Patients
• (HHS) ASCP Letter of Support for LTC Pharmacies to Be Able to Access Funds Appropriated Under Public Health and Social Services Emergency Fund (PHSSEF)
• (HHS) HHS Statements on Authorizing Licensed Pharmacists to Order and Administer: COVID-19 Tests
• (OSHA) Issued Emergency Temporary Standard (ETS)
• (USP) Compounding Alcohol-Based Hand Sanitizer During COVID-19 Pandemic

• Check out ascp.com/press for the latest news articles regarding COVID-19